tm logo
Trademark Search
CYTOSORB THERAPY REGAIN CONTROL

View On IC.GC.CA

CYTOSORB THERAPY REGAIN CONTROL
REGISTERED

on 27 Oct 2022

Last Applicant/ Owned by

CYTOSORBENTS CORPORATION

7 Deer Park DriveCity of Monmouth Junction, NJ 08852

US

Serial Number

1955474 filed on 04th Apr 2019

Registration Number

TMA1148330 registered on 27th Oct 2022

Registration expiry Date

27th Oct 2032

Correspondent Address

1100, boul. René-Lévesque Ouest25e ÉtageMontréal

QUÉBEC

CA

H3B5C9

CYTOSORB THERAPY REGAIN CONTROL

Trademark usage description

medical devices, namely, extracorporeal cytokine adsorber for treating the blood of patients who are at risk of or who have medically destabilizing co Read More

Classification Information

Class [010]
Medical devices, namely, extracorporeal cytokine adsorber for treating the blood of patients who are at risk of or who have medically destabilizing conditions such as the systemic inflammatory response syndrome, sepsis, infection, organ dysfunction and failure.

Classification kind code

11

Mark Details

Serial Number

1955474

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 190
on 12th Oct 2022		Registration Pending
Submitted for opposition 191
on 12th Oct 2022		Registration Fee Notice Sent
Submitted for opposition 42
on 20th Jul 2022		Advertised
Submitted for opposition 26
on 25th May 2022		Approved
Submitted for opposition 27
on 25th May 2022		Approval Notice Sent
Submitted for opposition 22
on 08th Oct 2021		Search Recorded
Submitted for opposition 20
on 08th Oct 2021		Examiner's First Report
Submitted for opposition 31
on 08th Apr 2019		Formalized
Submitted for opposition 1
on 05th Apr 2019		Created
Submitted for opposition 30
on 04th Apr 2019		Filed